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ABSTRACT 
Objective: The purpose of this research is to develop a Nanostructure Lipid Carrier (NLC) formulation containing of Retinyl Palmitate.  
Methods: Preparation of NLC was carried out by ultrasonication method. The formulas of NLC were developed by using virgin coconut oil and oleic 
acid as a liquid lipids, cetyl palmitate, and stearic acid as solid lipids, Tween 80 and Poloxamer as a surfactant and glycerine as co-surfactant. 
Characterization of NLC consisted of visual appearance, morphology, particle size, polydispersity index (PI), and physical stability test using freeze-
thaw, centrifugation, and accelerate stability test method.  
Results: Obtained NLC revealed a good characterization with the formulation of 7.2% of cetyl palmitate, 4.8% of oleic acid, 10% of Tween 80, 10% 
of glycerin, and 2% of retinyl palmitate. This NLC has a pale yellow appearance, globule size of 258±15.85 nm; and a polydispersity index of 
0.31±0.09. It was also physically stable after centrifuged at 13,000 rpm for 30 min, during 4 cycles of freeze-thaw and storage at room temperature 
for 28 d. During storage for 28 d, retinyl palmitate in NLC had been degraded only about 15% in comparison with macroemulsion destroyed almost 
50% of retinyl palmitate in the same time. 
Conclusion: NLC formulations with 7.2% cetyl palmitate, 4.8% of oleic acid, 10% of Tween 80, 10% of glycerol, and 2% of retinyl palmitate is the 
most optimal formula that showed a good characteristic. Stability study revealed that NLC provided better stability than macroemulsion. 
Keywords: Retinyl palmitate, NLC, Ultrasonication Methode 
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INTRODUCTION 
Nanostructure Lipid Carrier (NLC) is the second generation of lipid 
nanoparticle having a structure like nanoemulsion. The first 
generation was solid lipid nanoparticle (SLN). The difference between 
both of them is in its core. Both of them are a colloidal carrier in 
submicron size in the range of 40-1000 nm. SLN has a core which 
consists of one of solid lipid or a mixture of solid lipids while the core 
of NLC consists of a mixture of solid lipid and liquid lipid. Usually, SLN 
formulation can stable up to 3 y, has a good reproducibility, and can be 
delivered for various routes of administration such as intravenous, 
dermal, peroral or topical [1]. SLN also has the capability to protect 
degradation of active ingredient, to modulate of drug release, enhance 
the stability of sensitive active ingredients such as Co-enzyme Q10, 
Vitamin E, and Vitamin A, and has an ability to control the release of 
active ingredients [2]. Besides all of the advantages above, SLN still has 
any disadvantages such as a limitation of drug loading that depend on 
the solubility of active ingredient in the solid lipid and expulsion of 
drugs during storage caused by lipid crystallization [3]. 
NLC is developed to improve the disadvantages of SLN. The unique 
advantages of NLC such as enhanced of drug loading capacity and 
prevention of drug expulsion during storages make NLC is more 
favorable than SLN [2]. Recrystallization in NLC was less then SLN due 
to crstalline order in NLC was disturbed by oil particle to maintain the 
system in the form of liquid phase [1]. There were several method to 
construct NLC such as: High-Pressure Homogenization [4], O/W 
Microemulsion [5], Emulsification-solvent evaporation [6], multiple 
emulsion water/oil/water [6]. The high shear homogenization and/or 
ultrasonication were a dispersion technique which was not use an 
organic solvent, a large amount of surfactant or additive compound. 
The melting lipid was added and dispersed in a solution of surfactant 
using ultrasonication method [7]. The kind of ultrasonic equipment 
which usually use was probe sonicator [8]. 
Retinoid is a widely used ingredient in dermatology therapies of 
wrinkles. Retinol and retinyl palmitate are two compounds from the 
retinoid group which have an ability to induce the thickness of 
epidermis and effective as anti wrinkle agent. These substances is 
widely used as active ingredient in cosmetic products. Retinyl 
palmitate in the skin wills hydrolyze into retinol, which plays an 
important role on the regulation of epidermis cell growth. It is 
iniatate the final step of keratization, involve in synthesizer of 
collagen, prevent the atropi of connective tissue, increase the 
synthesizer of glicoaminoglican and essential substance in the 
reproduction of membrane basale cell [9]. Retinoid is an unstable 
drug which is easily to oxidized by light, oxygen and metal. 
Therefore it’s needed a special formula to prevent the retinoid 
degradation [10]. The aims of this study were to develop a good 
characteristic of NLC containing of retinyl palmitate. 
MATERIALS AND METHODS  
Materials 
Retinyl palmitate was provided from PT Kimia Farma, Cethyl 
palmitate and Poloxamer 188 were purchased from BASF Indonesia, 
Oleic acid, Tween 80, Glycerin, and stearic acid were purchased from 
local market, Virgin Coconut Oil (VCO) was purchase from LIPI.  
Instruments 
Analytical balance (Mettler Toledo, USA), Heater stirrer, Ultraturax, 
Sonicator probe, High Pressure Liquid Chromatography (Hewlett 
Packard Agilent Series 1100), Climatic Chamber (Hotpack), pH 
Meter (Mettler Toledo S20), particle size analizer (DelsaTM
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Particle Analyzer, Beckman Coulter, USA), Transmission Electron 
Microscopy (Dept Physic of Gajah Mada University), microcentrifuge 
(Eppendorf), micropipette (Eppendorf), and other general 
laboratory glasswares.  
NLC formula optimization was done using various combinations of 
lipid, oil and surfactant concentration. The used lipid compounds in 
this study were stearic acis and cethyl palmitate. Meanwhile the oil 
compounds were VCO and oleic acid, surfactant were Tween 80 and 
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Poloxamer 188 and as co-surfactant was glycerine. For oil phase: 
First the lipid component was melting then mixed with the oil. 
Water phase: Surfactant and co-surfactant were dissolved in 
deionized water. Then both phases were heated up until 60-70 °C, 
mixed and stirred using ultra turax at 9800 rpm for 5 min. The next 
step the emulsion was sonicated using probe sonicator at an 
amplitude of 60 kHz for 1 minute and 45 seconds which on-off 
period of 30 seconds and 5 seconds respectively. The emulsion were 
kept at room temperature for 24 h and the nanoparticles size were 
measured. The NLC formula with particle sizes in the range of 200-
300 nm is choosen for further investigation. Retinyl palmitate was 
added to the choosen formulas and optimization was carried out 
again until the target particle size were obtained.  
Particle sizes analysis 
The nanoparticles size of NLC were measured using Delsa Nano-C 
Particle Analyzer. The obtained data were polydispersity index and 
means of nanoparticles size. The polydispersity index (PI) measured 
nanoparticles size distribution [2]. The good value of PI was ≤ 0.5. 
Morphology of nanoparticles 
The nanoparticles morphology were observed by using 
Transmission Electron Microscope (TEM) Jeol JEM 1400. Samples 
were mixed with aqua bidest and keep in the carbon film with 1% of 
Phosphotungstate acid and dried. Then the samples were ready to 
observe by TEM. 
NLC physical stability test [11] 
NLC was kept at room temperature. Different parameters, namely 
nanoparticles sizes, PI, and pH were determined during stability 
studies. All parameters were measured at the day of 0, 7, 14, 21, 28 
after storage.  
The effect of centrifugation to the physical stability of NLC was also 
observed at 13,000 rpm for 30 min. The NLC is said to be stable if 
there was no separation of oil phase occurred after centrifugation is 
processed. 
The physical stability of NLC against extreme fluctuation of 
temperature was also observed by doing Freeze-Thaw test for six 
cycles. Each cycle consist of 48 h storage at a temperature of 4 °C 
followed by 48 h storage at a temperature of 40 °C. At the end of 
each cycle the nanoparticles size and PI of NLC were measured. The 
value of zeta potential of the system was also determined after 0, 3, 
and 6 cycles. The NLC is said to be stable if there was no oil phase 
separation and significant change of its nanoparticles size. 
Accelerated stability test 
The dosage forms were kept in Climatic Chamber at a temperature 
of 40±2 °C and humidity of 75±5% for 25 d. The remaining of retinyl 
palmitate is determined using HPLC method using mobile phase of 
acetonitrile and UV detector at wavelenght of 325 nm. First retinyl 
palmitate NLC is dissolved in acetone and centrifuged. The clear 
acetone phase is withdraw and evaporated. Then the residue is 
dissolved in acetonitrile and injected to HPLC instrument [12].  
Statistical analysis  
The difference of mean particle sizes between NLC and 
microemulsion was analyzed statistically using one-way ANOVA 
during 28 d of storage. Furthermore, stability profile of retinyl 
palmitate in NLC is compared with retinyl palmitate in 
macroemulsion, and the result is analyzed statistically using one-
way ANOVA at α=0.05 (significance level of 0.05). 
RESULTS AND DISCUSSION 
Preparation of Nanostructure Lipid Carrier (NLC) using 
ultrasonication method 
The materials for constructed NLC are consist of solid lipids such as 
stearic acid and cetyl palmitate. Virgin Coconut Oil (VCO) and oleic 
acid were used as liquid lipids and Tween 80 and Poloxamer 188 were 
used as surfactants. Glycerine was also used in the NLC formula as co-
surfactant. Optimation of the formulation to obtained the stable NLC 
were completed using various combination of all the components and 
the results obtained from each formula is shown at table 1. 
                                                                                                                                                           


















1 3   2   1     Breaking 
2 2.40   1.60   1     Breaking 
3 1.80   1.20   1     Breaking 
4 2.40   1.60   2     Breaking 
5 1.80   1.20   2     Breaking 
6 1.20   0.80   2     Breaking 
7 1.80   1.20     1   Semisolid 
8 1.80   1.20     2   Semisolid 
9 1.20   0.80   1.50 1.50   Breaking 
10 1.20   0.80   2.50 2.50   Breaking 
11 1.20   0.80     5 4 Semisolid 
12 1.20   0.80   5   4 Breaking 
13   1.20 0.80   1     Breaking 
14  1.20 0.80  2   Breaking 
15   1.20 0.80    2   Semisolid 
16   1.20   0.80 5   5 Breaking 
17   1.20   0.80   5 5 Semisolid 
18   1.20   0.80 10   10  Stable  
19   1.20   0.80   10 10 Semisolid 
 n= 3 samples observation 
 
The NLC formulation was prepared using ultrasonication method. 
First the mixture of melting lipids components were blended with a 
surfactant, co-surfactant, glycerin and deionized water at 60-70 °C. 
This mixture is stirred with Ultraturax at 9800 rpm for 5 min. 
Immediately this pre-emulsion is sonicated using Probe 
Ultrasonicator at an amplitude of 50 kHz for 2 min. Then the 
obtained NLC was kept at room temperature for 24 h. 
Base on the results of optimation formulation at table 1, it was found 
that Poloxamer 188 was not suitable for formation of NLC. The 
results obtained from the formula that using Poloxamer 188 was 
semisolid dosage forms, so its nanoparticles size can not be 
measured. The formation of semisolid dosage forms by Poloxamer 
188 was due to its thermogelling properties. Poloxamer consist of 
block copolymer of ethylen oxyde and proylen oxyde. This 
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temperature-dependent self-assembling and thermogelling 
characters has already known  
In water, Poloxamer has an ability to change its form, namely from 
an individual block of co-polymer (unimer) into a group of micelles. 
At the concentration below the Critical Micelle Concentration (CMC), 
the unimer will disperse in water while at the concentration over the 
CMC, they unimer will agregate to form micelles. The formation of 
micelles is depends on temperature or Critical Micellization 
Temperature (CMT). Below the CMT, the molecule of Poloxamer is in 
the form of unimer, while over the CMT the aggregation will occur 
following by the formation of gel [13]. 
The formulation that using a combination of Tween 80 and 
Poloxamer 188 as surfactants is also yielded a semisolid or 
unstable NLC. The addition of co-surfactant glycerine into the 
formulation can not improve the performance of NLC. Therefore, 
the formulations that using Tween 80 as the surfactant is selected 
for further development. The best formulation was showed by a 
combination of cetyl palmitate as solid lipid and oleic acid as liquid 
lipid or oil (table 1). The other formulas were in the form of 
unstable emulsions. It is suggested that the surfactant and 
cosurfactant used in these formulas were not able to construct the 
densed layer surrounding the nanoparticles. Therefore its have a 
tendency to become coalescence.  
The preparation of NLC was performed using ultrasonication method. 
This instrument produced a strong vibration that can break lipid 
nanoparticles into a smaller diameter of nanoparticles, hence increases 
the surface area and surface free energy. It is needed a large amount of 
surfactant to cover all the surface of the nanoparticles and stabilized the 
system. If there was an uncovered surface of nanoparticles, it can be a 
trigger to cause a coalescence of the nanoparticles [14]. 
The next optimation was to find the concentration of each material 
in the formulation that can produce the NLC with a diameter of 
nanoparticles in the range of 200-300 nm, because the target that 
has to be reached was retinoic acid responsive elements (RAREs) in 
the epidermis [15]. The ratio between solid and liquid lipid was 
constant at 60:40. The NLC formulas were developed with various 
concentration of oil phase and surfactants as shown in table 2. The 
next day after preparation the diameter of nanoparticles and 
polydispersity index form each formulation were analyzed. The 
measurement of diameter nanoparticles was very important. It can 
be used to observe the physical instability of the products. The 
increasing of nanoparticles size during the storage is indicated the 
unstable of NLC. The diameter of nanoparticles can be affected by 
various factors suh as the composition of the formulation, production 
method, and concentration of surfactant and co-surfactant. In general, 
the smaller of the nanoparticles size, the higher of the ratio between 
surfactants and lipids needed to stabilize the formula [1]. 
 
Table 2: Optimation of concentration of oil phase, surfactants, and cosurfactant used in the NLC formulation 
Formula Oil phase (%) Surfactant (%) Co-surfactant (%) Particles size (nm) PI 
F20 3 10 10 24.60±0.82 0.41±0.05 
F21 4 10 10 26.37±2.36 0.34±0.08 
F22 4 8 8 247.33±24.90 0.45±0.05 
F23 5 8 8 312.87±16.16 0.31±0.04 
F24 10 10 10 73.33±6.00 0.34±0.03 
F26 12 10 10 230.60±38.41 0.36±0.09 
F27 15 10 10 400.53±48.31 0.28±0.02 
n= 3 time measurement 
 
Base on the result at table 2, it was found that the formulas of F20 
and F21 have the smallest of nanoparticles size. The concentration 
of surfactant and co-surfactant in these formulas were relatively 
high so it can improve the surface area that can cover the small 
nanoparticles. Therefore, in the formulation of F 22 the 
concentration of surfactant-co-surfactant were reduced. The result 
obtained from this formulation was fulfill the size target of 
nanoparticles. However, the concentration of oil phase in the 
formula was too low to load the active ingredient. Therefore, the 
next step of optimation was to improve the concentration of oil 
phase. The F26 (consist of 12 % of oil phase) fulfilled the 
nanoparticles size target (table 2). The PI value from all of the 
formulation was ≤ 0.5. These value indicated that the distribution of 
particle size of the NLC was narrow distribution. The lower of the 
value of PI the higher of homogeneity in the dosage forms [15]. 
Optimation of retinyl palmitate loading into NLC 
It has to be considered that loading of retinyl palmitate into the NLC 
can increase the particle size. So next optimation was to find the 
formulation that can load high concentration of retinyl palmitate but 
still fulfill the particle size target. The formula of F25 and F26 were 
chosen for this purpose. The result obtained from this optimization 
is shown in table 3 and fig. 2. 
 
 
Fig. 1: Visual appearence of l NLC retinyl palmitate: (A) F25-1, 
(B) F25-2, (C) F25-3, (D) F25-4, (E) F26-1, (F) F26-2, (G) F26-3 
 
Table 3: Optimation of retinyl palmitate loading into NLC 
Oil phase (%) Surfactant (%) Formula Co-surfactant (%) RP (%) Particle size (nm) PI 
10 10 F25-1 10 0.5 55.43±7.65 0.31±0.15 
10 10 F25-2 10 2 135.33±11.34 0.38±0.05 
10 10 F25-3 10 3 343.00±9.53 0.28±0.02 
10 10 F25-4 10 4 628.90±32.29  0.31±0.07 
12 10 F26-1 10 1 159.03±20.66 0.36±0.02 
12 10 F26-2 10 2 258.00±15.85 0.31±0.09 
12 10 F26-3 10 4 737.60±29.20 0.27±0.02 
n= 3 time measurement. 
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Base on the result in table 2 and fig. 2, the higher concentration of 
retinyl palmitate loading NLC, the most cloudy appearance of NLC. 
The translucent of the NLC performance is indicated that its particle 
size was smaller than the wave length of visible light [16]. The best 
formula obtained from this optimization was showed by the formula 
of F26-2 that consists of oil phase of 12%, the surfactant of 10%, Co-
surfactant of 10%, and retinyl palmitate of 2%. This formula will be 
further characterized. 
Morphology of NLC core 
The morphology of NLC lipid core sample was determined using 
Transmission electron micrograph (TEM). The result obtained from 
this study showed that the lipid core of NLC was spherical with a 
diameter in the range of 200-300 nm. 
Physical stability study of NLC 
The study was performed by keeping the NLC samples at room 
temperature. During storage, particle sizes, polydispersity index, 
and pH of the samples were analyzed at days of 0, 7, 21, 28. The 
result obtained from this study is shown at table 4. 
The particles size of retinyl palmitate NLC were increased during 28 
d of storage, but this alteration was still in the range of targeted 
diameter of NLC. The difference of mean particle sizes was analyzed 
statistically using one-way ANOVA and it was found that there were 
no significant changes between the particle size of NLC particles 
during 28 d of storage. The value of PI was still less than 0.5. It 
means that the distribution of particle size was still good.  
The physical instability of emulsion can be detected if there are 
phenomena of creaming, separation of oil phase or sedimentation of 
a component that has a high density occurred in the emulsion. The 
formation of these phenomena can accelerate by using 
centrifugation [17]. There were no such phenomena observed for 
F26-2 after centrifugation at 3000 RPM for 30 min. 
The freeze-thaw test was carried out to observe the physical stability 
of emulsion during the fluctuation of temperature. One cycle of the 
freeze-thaw test was consist of 48 h of storage at 4 °C and 48 h storage 
at 40 °C. The parameters of particles sizes, polydispersity index, and 
zeta potential of the samples were measured during 4 cycles of freeze-
thaw test, and the result is shown at table 5. 
 
 
Fig. 2: The morphology of retinyl palmitate NLC: (A) magnification of 10000x, (B) magnification of 20000x, and (C) magnification of 40000x 
 
Table 4: Physical stability of NLC at room temperature for 28 d 
Days of Particle sizes (nm) PI pH 
0 259.27±20.14 0.29±0.01 4.76±0.04 
7 261.47±23.15 0.34±0.02 4.6±0.03 
21 268.2±0.34 0.34±0.02 4.5±0.11 
28 283.33±24.71 0.33±0.05 4.32±0.11 
n= 3 time measurement. 
 
Table 5: Particles size, polydispersity index (PI) and zeta potential of retinyl palmitate NLC during freeze-thaw test 
Cycles Nanoparticles size (nm) PI Zeta Potential (mV) 
0 259.3±20.14 0.29±0.01 -0.27 
1 283.33±24.71 0.33±0.04 - 
2 375.5±12.14 0.31±0.05 - 
3 584.1±22.55 0.32±0.04 -1.19 
4 728.93±52.25 0.31±0.05 - 
n= 3 time measurement. 
 
At the end of first cycles, the diameter of nanoparticles was still in 
the range of the target. But the size of the nanoparticles was 
continuously increase after the next cycles. After 4th
The value of zeta potential can be used to predict the stability of 
dispersing system potential during the storage. The decreasing of 
zeta potential value is indicate the decreasing of physical stability of 
the system. However, this rule was not valid for the disperse system 
which is stabilized by steric mechanism [1]. Although there was an 
alteration of zeta potential during the freeze-thaw test, it can not be 
use to predict the stability of NLC. The value of zeta potential of F26-
2 NLC was very small (table 5) because the used emulsifying agent 
in this formula works as sterical mechanism. 
 cycles, the NLC 
was broken. These phenomena were presumed because of the 
redissolution rate of the emulsifying agent was slow after freezing, 
and induced the coalescence of the nanoparticles and finally the 
phase separation was occurred.  
Accelerated stability test 
Chemical stability study was accomplished in Climatic Chamber at 
temperature of 40±2 °C and humidity of 75±5% for 28 d.  
According to an accelerated stability study at fig. 3 reveals 
decreasing the concentration of retinyl palmitate in macroemulsion 
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was faster in comparison with NLC. During storage for 28 d retinyl 
palmitate in NLC was only about 15% destroyed in comparison with 
macroemulsion was destroyed almost 50% of retinyl palmitate in 
the same time. 
 
 
Fig. 1: Remaining retinyl palmitate concentration in NLC () 
and macroemulsion (-●-
All authors have none to declare. 
) after stability study in period of 28 d 
(n= 3 time measurement) 
 
In this case indicate that NLC was better to protect retinyl palmitate 
against stressing from the environment such as light, temperature or 
hydrolysis degradation by water surrounding lipid nanoparticles. 
Stability profile of the both formulation was different according to 
one-way ANOVA with a significance level of 0.05 (α=0.05). The tested 
NLC formulation was a standard formulation that needed to improve 
the stability of retinyl palmitate against environment stressing. During 
maximum storage retinyl palmitate degradation is considered below 
5%, therefore improving stability can be accomplished by adding 
antioxidant, chelating agent or another specific preparation. 
CONCLUSION 
The best formula of this study was the NLC formulation that consists 
of 7.2% of cetyl palmitate, 4.8% of oleic acid, 10% of Tween 80, 10% 
of glycerine, and of 2% retinyl palmitate. This formula has a pale 
yellow appearance with a particle size of 258±15.85 nm, and a 
polydispersity index of 0.31±0.09. It was also stable at room 
temperature for 28 d, after centrifugation at 13000 rpm for 30 min 
and 4 cycles of the freeze-thaw test. NLC was better to protect 
retinyl palmitate against stressing from the environment in 
comparison with macro emulsion. 
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